Armenian banks’ overdrafts amounted to 275.9bln drams in Q2

YEREVAN, August 22. /ARKA/. Overdrafts paid by Armenia’s commercial banks in the second quarter of 2013 against the quarter before rose by 16.1% to 275.9 billion drams, according to an intermediate report analysis by ARKA Agency.

Bank VTB (Armenia) is the leader in overdrafts to clients by the end of June 2013, with a total of 115 billion drams paid in overdraft, an increase of 2.7% against the quarter before. Overdrafts were 59.2% of overall bank borrowing by Bank VTB (Armenia).

Among leaders in amount of overdrafts are also Unibank with 40. 1bln drams (no data available for Q1), Ardshininvestbank with 37.1bln drams (4.2% reduction), Armbusinessbank with 26.3bln drams (3.7% reduction) and Artsakhbank with 19.1bln drams (1.7% increase).

There were 21 commercial banks (with 478 branches) operating in Armenia as of the end of June 2013. ($1= 406.27drams).–0–

spot_img

POPULAR

Armenian banks will provide citizens with account statements free of charge

Individuals in Armenia will be able to receive free electronic statements from commercial banks about their bank accounts, their balances, and the presence or absence of mutual obligations with the bank.

Armenian banks’ investments in securities in the second quarter amounted to 1.92 trillion drams

The total volume of investments by Armenian commercial banks in securities as of the end of June 2026 amounted to 1,922,826,829 thousand drams.

Armbanks Weekly Digest: Key Events in the Armenian Financial Market (August 17–23)

Key developments in Armenia's financial market this week included new banking compliance requirements, measures against account fraud, and decisions related to capital market development.

Shares of Noubar Afeyan’s Moderna soared 124% on news of a successful cancer vaccine trial

YEREVAN, August 20. /ARKA/. Shares of the biotech company Moderna soared 123.6% at the start of trading in the US on August 19, reaching a peak of $140.77, according to trading data. Shares of the pharmaceutical company Merck also rose 11.6% to $150.85, according to Forbes.ru.

S&P affirms Armenia’s ratings, maintaining a positive outlook

The international rating agency S&P Global Ratings affirmed the long- and short-term sovereign ratings of the Republic of Armenia at 'BB-/B', maintaining a positive outlook, the Ministry of Finance reported.

LATEST NEWS

spot_imgspot_imgspot_img